LifeVantage
Corporation (OTCBB:LFVN), the makers of Protandim®,
the only product clinically proven to slow the progressive rate of
aging, announced today that network marketing executive Randal Wojta has
been named as the Master Distributor for LifeVantage's launch into the
network marketing arena.
David Brown, LifeVantage President and CEO said, "Mr. Wojta was selected
as the Master Distributor for LifeVantage based on his exceptional
qualifications, which include over 20 years of success in the network
marketing industry. Randy has been a leader and top producer at some of
the top network marketing organizations in the world, including NuSkin,
consistently demonstrating outstanding leadership as a top recruiter,
trainer and sales executive. Randy brings significant industry knowledge
and expertise to the Company, and has already been effective in helping
our company attract key new distributors."
"It is an exciting opportunity to be named as the Master Distributor for
LifeVantage," said Mr. Wojta. "Billions of dollars are spent annually by
consumers in the battle against aging, and in the United States alone,
the network marketing industry accounts for approximately $7.9 billion
in sales. The potential for Protandim sales is immense, as the product
and its benefits are backed by clinical proof. The direct sales model
allows distributors the opportunity to fully share the product's
numerous benefits and uses."
About Randal Wojta
Randal Wojta has served as an executive in the network marketing
industry for the past 20 years. He has an impressive track record in
building large sales organizations, both nationally and internationally.
Mr. Wojta has successfully led network marketing organizations in the
areas of sales, marketing, internet, product development, research and
organizational structure. In addition, he has an in-depth understanding
of building network marketing organizations and developing compensation
plans, having launched several early stage companies. Prior to joining
LifeVantage, Mr. Wojta played a key role as a top distributor and sales
leader in launching new markets for network marketing organizations
including NuSkin International, Market America, InnerLight and others.
He helped develop training systems and tools for those organizations,
and served as a corporate trainer, coach, and board member. Mr. Wojta
consistently set records for first year income worldwide, fastest
growing distributor, and other sales areas. In addition, he has served
as a consultant for a number of network marketing companies, and also
served as CEO for The Edge Sports Training Center, as well as CEO of
Nature Rich.
About
Protandim®
Protandim® is a groundbreaking, clinically proven solution
for healthy aging. This patented anti-oxidant therapy is 1000's of times
more powerful than red wine, oranges, blueberries, acai juice or other
popular anti-oxidant supplements. Protandim works by increasing the
body's natural anti-oxidant protection at the cellular level, triggering
cells to produce naturally occurring protective antioxidant enzymes such
as super oxide dismutase (SOD), catalase, and glutathione.
A peer-reviewed scientific study shows that after 30 days of taking
Protandim, free radicals decreased an average of 40 percent, slowing the
progressive aging factors to the level of a 20 year old. Protandim is
currently the subject of over 20 scientific studies at leading
universities and research institutes. For more information, please visit www.LifeVantage.com
or contact Jan Strode at (619) 890-4040.
About
LifeVantage Corporation
LifeVantage Corporation is a publicly traded (OTCBB:LFVN), science
based, natural products company, dedicated to helping people reach their
health and wellness goals through science-based solutions to oxidative
stress. Founded in 2003 and based in San Diego, CA, LifeVantage develops
nutraceutical products, including Protandim
that leverage the company's expertise and that are intended to deliver
significant health benefits to consumers. For more information, visit www.LifeVantage.com
or contact Jan Strode at (619) 890-4040.
This document contains forward-looking statements made pursuant to
the safe harbor provisions of the Private Securities Litigation Reform
Act of 1995.The Company uses the words "anticipate," "believe,"
"could," "should," "estimate," "expect," "intend," "may," "predict,"
"project," "plan," "target" and similar terms and phrases, including
references to assumptions, to identify forward-looking statements.These
forward-looking statements are based on the Company's current
expectations and beliefs concerning future events affecting the Company
and involve known and unknown risks and uncertainties that may cause the
Company's actual results or outcomes to be materially different from
those anticipated and discussed herein.These risks and
uncertainties include, among others, the risk that government regulators
and regulations could adversely affect our business; future laws or
regulations may hinder or prohibit the production or sale of our
existing product and any future products; unfavorable publicity could
materially hurt our business; and the Company's ability to protect our
intellectual property rights and the value of our product.These
and other risk factors are discussed in greater detail in the Company's
Annual Report on Form 10-KSB under the caption "Risk Factors", and in
other documents filed by the Company from time to time with the
Securities and Exchange Commission.The Company cautions
investors not to place undue reliance on the forward-looking statements
contained in this document.All forward-looking statements are
based on information currently available to the Company on the date
hereof, and the Company undertakes no obligation to revise or update
these forward-looking statements to reflect events or circumstances
after the date of this document, except as required by law. These
statements have not been evaluated by the Food and Drug Administration.
This product is not intended to diagnose, treat, cure or prevent any
disease.
Note to Editors: Contact Jan Strode at 619-890-4040 or Jean Golden at
612-385-2324 for interviews, photography, and other requests.
LifeVantage Corporation
Jan Strode, 619-890-4040
Jean Golden,
612-385-2324